Share Awards to Executive Directors | 22-Mar-2024 | 07:00 | RNS |
Replacement: Trading Update | 21-Mar-2024 | 09:13 | RNS |
Trading Update | 21-Mar-2024 | 07:00 | RNS |
General Meeting Result | 19-Mar-2024 | 09:40 | RNS |
Publication of Notice of General Meeting | 27-Feb-2024 | 07:00 | RNS |
Disposal of Freehold Properties | 08-Jan-2024 | 07:00 | RNS |
Holding(s) in Company | 05-Jan-2024 | 17:05 | RNS |
Holding(s) in Company | 05-Jan-2024 | 17:00 | RNS |
Deferred Option Awards to Executive Directors | 22-Dec-2023 | 07:00 | RNS |
Director/PDMR Shareholding | 01-Dec-2023 | 07:00 | RNS |
Results for the six months ended 30 September 2023 | 27-Nov-2023 | 07:00 | RNS |
Holding(s) in Company | 14-Nov-2023 | 15:00 | RNS |
Capital Markets Day Events | 09-Nov-2023 | 07:00 | RNS |
New USA and Canada label claim for AivlosinÂ... | 24-Oct-2023 | 07:00 | RNS |
Result of AGM | 07-Sep-2023 | 14:57 | RNS |
Currency | UK Pounds |
Share Price | 85.50p |
Change Today | 1.50p |
% Change | 1.79 % |
52 Week High | 122.50 |
52 Week Low | 83.15 |
Volume | 186,890 |
Shares Issued | 67.74m |
Market Cap | £57.92m |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 1 |
Buy | 2 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 3 |
Latest | Previous | |
---|---|---|
Final | Final | |
Ex-Div | 23-Sep-21 | 26-Sep-19 |
Paid | 22-Oct-21 | 16-Oct-19 |
Amount | 1.00p | 7.04p |
Time | Volume / Share Price |
17:08 | 8,000 @ 85.50p |
15:42 | 50,000 @ 85.00p |
15:41 | 649 @ 84.30p |
14:44 | 1,500 @ 84.75p |
14:30 | 4,500 @ 84.75p |
CFO | Christopher Wilks |
CEO | David Hallas |
You are here: research